Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of "Hold" by Brokerages

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been given an average recommendation of "Hold" by the eighteen research firms that are currently covering the stock, MarketBeat Ratings reports. Eleven research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $10.94.

Several equities research analysts have commented on the stock. Bank of America decreased their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday. The Goldman Sachs Group lowered their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Piper Sandler lowered their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Finally, Royal Bank of Canada lifted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th.

Teladoc Health Stock Performance

Shares of TDOC stock traded down $0.05 during trading hours on Friday, hitting $7.20. The stock had a trading volume of 5,324,540 shares, compared to its average volume of 6,238,474. The firm has a market capitalization of $1.26 billion, a PE ratio of -1.25 and a beta of 1.73. The stock's 50 day moving average is $9.66 and its 200 day moving average is $9.70. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a twelve month low of $6.61 and a twelve month high of $15.21.

Remove Ads

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, research analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the period. Point72 Asset Management L.P. raised its stake in shares of Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after acquiring an additional 763,265 shares in the last quarter. Geode Capital Management LLC increased its holdings in Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. raised its position in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after purchasing an additional 2,331,000 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.